Spoiler, I haven't read the article, but my understanding is cardiolipin targeting antibiotics have failed in the past because our mitochondria are enriched for it. (Which makes sense here because the mitochondria are derived from ancient bacteria). I'm sure there is potential for optimization for medical applications, but we will have to be very careful for adverse effects.